People Background Check
Find People:

Scott Fuller Childs Deceased635 Stock Gap Rd, Monroe, GA 30656

Get Report
Known as:
Scott F Childs Scott E Childs Scott Chiles Scott Childs Fuller Professiona Fire Gwinnett
Related to:
Donna Martin Patton 67

Scott Childs Phones & Addresses

635 Stock Gap Rd, Monroe, GA 30656

Snellville, GA

Loganville, GA

Education

Degree: Associate degree or higher

Mentions for Scott Fuller Childs

Scott Childs resumes & CV records

Resumes

Scott Childs Photo 50

Experienced Solid State Chemist And Pharmaceutical Executive, Pharmaceutical Cocrystal Applications Expert

Location:
Greater Atlanta Area
Industry:
Pharmaceuticals
Scott Childs Photo 51

Scott Childs

Scott Childs Photo 52

Senior Vice President At Huntington National Bank

Position:
Senior Vice President at Huntington National Bank
Location:
Denver, Colorado
Industry:
Banking
Work:
Huntington National Bank - Greater Denver Area since Aug 2013
Senior Vice President KeyBank National Assocation Sep 1988 - Jul 2013
Senior Vice President
Education:
Cleveland State University 1988 - 1994
Scott Childs Photo 53

Scott Childs

Location:
United States

Publications & IP owners

Us Patents

Metronidazole Cocrystals And Imipramine Cocrystals

US Patent:
8163790, Apr 24, 2012
Filed:
Dec 8, 2006
Appl. No.:
12/096998
Inventors:
Scott Lawrence Childs - Atlanta GA, US
Assignee:
New Form Pharmaceuticals, Inc. - New York NY
International Classification:
A61K 31/4164
A61K 31/55
C07D 233/92
C07D 233/18
US Classification:
514398, 5483265, 540476, 51421301
Abstract:
Cocrystals of metronidazole are described herein. Such cocrystals are a cocrystal of metronidazole with gentisic acid and a cocrystal of metronidazole with gallic acid. Cocrystals of imipramine hydrochloride are also described. Such cocrystals are a cocrystal of imipramine hydrochloride with (+)-camphoric acid, a cocrystal of imipramine hydrochloride with fumaric acid, and a cocrystal of imipramine hydrochloride with 1-hydroxy-2-naphthoic acid.

Cocrystallization

US Patent:
8212079, Jul 3, 2012
Filed:
Sep 19, 2008
Appl. No.:
12/234093
Inventors:
Scott L. Childs - Atlanta GA, US
Assignee:
Aptuit (West Lafayette), LLC - West Lafayette IN
International Classification:
A61K 31/44
C07C 213/00
US Classification:
564347, 568328, 424666, 562405
Abstract:
The present disclosure relates to novel cocrystals and novel methods for cocrystallization. In particular, the disclosure includes cocrystals comprising a salt of an active agent, such as a chloride salt of an active pharmaceutical ingredient. The present disclosure also relates to methods of preparing cocrystals and methods for screening for solid state phases.

Cocrystallization

US Patent:
8350085, Jan 8, 2013
Filed:
Jun 28, 2011
Appl. No.:
13/170701
Inventors:
Scott L. Childs - Atlanta GA, US
Assignee:
New Form Pharmaceuticals Inc. - New York NY
International Classification:
C07C 63/70
US Classification:
564347, 562405, 424666
Abstract:
The present disclosure relates to novel cocrystals and novel methods for cocrystallization. In particular, the disclosure includes cocrystals comprising a salt of an active agent, such as a chloride salt of an active pharmaceutical ingredient. The present disclosure also relates to methods of preparing cocrystals and methods for screening for solid state phases.

Novel Cocrystallization

US Patent:
2004017, Sep 9, 2004
Filed:
Jan 21, 2004
Appl. No.:
10/763987
Inventors:
Scott Childs - Atlanta GA, US
International Classification:
A61K031/60
A61K031/19
US Classification:
514/165000, 514/557000, 514/568000, 514/574000
Abstract:
The present disclosure relates to novel cocrystals and novel methods for cocrystallization. In particular, the disclosure includes cocrystals comprising a salt of an active agent, such as a chloride salt of an active pharmaceutical ingredient. The present disclosure also relates to methods of preparing cocrystals and methods for screening for solid state phases.

Cocrystallization Methods

US Patent:
2007008, Apr 19, 2007
Filed:
Sep 27, 2006
Appl. No.:
11/527395
Inventors:
Scott Childs - Atlanta GA, US
International Classification:
G06F 19/00
US Classification:
702019000
Abstract:
Methods for preparing cocrystals wherein solutions of active agents in suitable liquids are combined with solutions of guests, both with and without suitable liquids, in an interface region are described herein. Methods for analyzing the cocrystals are also described.

Screening For Solid Forms By Ultrasound Crystallization And Cocrystallization Using Ultrasound

US Patent:
2007028, Dec 13, 2007
Filed:
Mar 14, 2005
Appl. No.:
10/592591
Inventors:
Scott Childs - Atlanta GA, US
Barbara Stahly - West Lafayette IN, US
International Classification:
G01N 1/00
B01D 9/00
C30B 7/00
US Classification:
436181000, 117011000, 02329500R
Abstract:
The present disclosure relates to crystallizing a chemical substance(s) using ultrasound. Methods are provided for screening a chemical substance according to its solid forms by using ultrasound to generate new or unusual solid forms. Methods are also provided for crystallizing a chemical substance by novel techniques that include sonication. The present disclosure also relates to cocrystallization using ultrasound. Methods are provided for preparing cocrystals of an active agent and a guest by sonicating and crystallizing. Methods are also provided for screening a sample according to solid state phases (such as cocrystals and salts) and include generating a cocrystal from the sample using ultrasound.

Crystalline And Amorphous Forms Of Tiagabine

US Patent:
2008005, Feb 28, 2008
Filed:
Aug 16, 2007
Appl. No.:
11/893524
Inventors:
Scott Childs - Atlanta GA, US
Karen Gushurst - West Lafayette IN, US
R. Haltiwanger - West Chester PA, US
Robert McKean - Chester Springs PA, US
Donglai Yang - West Lafayette IN, US
Assignee:
Cephalon, Inc. - Frazer PA
International Classification:
C07D 409/14
A61K 31/4535
US Classification:
514326000, 546212000
Abstract:
The present invention provides 24 new forms of tiagabine, including 22 new crystalline forms of tiagabine and its salts, an amorphous form of tiagabine free base, and a cocrystal form of tiagabine hydrochloride with 2-furancarboxylic acid. The present invention further provides a process for preparing each of the new tiagabine forms. The present invention further provides a pharmaceutical composition containing at least one of the new tiagabine forms, and a process for the preparation thereof. The present invention further provides a method of treating a disease related to GABA uptake in a mammal, comprising the step of administering to the mammal a therapeutically effective amount of at least one of the new tiagabine forms.

Crystalline Forms Of Tiagabine Hydrochloride

US Patent:
2008006, Mar 13, 2008
Filed:
Aug 16, 2007
Appl. No.:
11/893618
Inventors:
Scott Childs - Atlanta GA, US
Leonard Chyall - Lafayette IN, US
Karen Gushurst - West Lafayette IN, US
R. Haltiwanger - West Chester PA, US
Robert McKean - Chester Springs PA, US
Donglai Yang - West Lafayette IN, US
Assignee:
Cephalon, Inc. - Frazer PA
International Classification:
A61K 31/496
A61P 25/00
C07D 409/14
US Classification:
514326000, 546212000
Abstract:
The present invention provides 16 new crystalline forms of tiagabine hydrochloride.

Possible Relatives

David N Childs  Dawn K Childs  Debora A Childs  Debra L Childs  Aaron T Childs  Delores G Childs  Danielle Childs  Scott S Stanard  Scott A Standefer  Scott C Johnston 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.